Omeros (OMER) Gross Margin (2014 - 2026)
Omeros (OMER) posted Gross Margin of 94.07% for Q1 2026, down 31.42% sequentially from 137.17% in Q4 2021.
Powered by 
Analysis
Omeros (OMER) Gross Margin (2014 - 2026) Analysis & Trends
Omeros has reported Gross Margin for 9 years, with the latest figure at 94.07% in Q1 2026.
- Quarterly Gross Margin changed N/A year-over-year to 94.07% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 261.58% (down 34349.0% YoY) and the FY2020 annual result came in at 98.78%, down 45.0% from the prior year.
- Gross Margin retreated to 94.07% in Q1 2026 per OMER's latest filing, from 137.17% in the prior quarter.
- Over five years, Gross Margin peaked at 94.07% in Q1 2026 and troughed at 94.07% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 35.86% |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 89.76% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 76.90% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 84.20% |
| 10 | Omeros | 1.37 Bn | 1.37 Bn | 27.73 Mn | 97.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 97.20% |
| Mar 31, 2026 | 94.07% |
| Dec 31, 2021 | 3.74% |
| Sep 30, 2021 | 98.89% |
| Jun 30, 2021 | 98.81% |
| Mar 31, 2021 | 98.75% |
| Dec 31, 2020 | 99.18% |
| Sep 30, 2020 | 98.46% |
| Jun 30, 2020 | 98.91% |
| Mar 31, 2020 | 98.87% |
| Dec 31, 2019 | 98.80% |
| Sep 30, 2019 | 99.07% |
| Jun 30, 2019 | 99.79% |
| Mar 31, 2019 | 99.40% |
| Dec 31, 2018 | 99.29% |
| Sep 30, 2018 | 99.22% |
| Jun 30, 2018 | 92.99% |
| Mar 31, 2018 | 87.22% |
| Dec 31, 2017 | 96.62% |
| Sep 30, 2017 | 99.15% |